Marieke J. Kruip

Hematologist
Department of Hematology, Erasmus MC, Erasmus University Medical Centre Rotterdam, Rotterdam, the Netherlands
Rotterdam, Zuid-Holland, Netherlands

Presentation(s):

• PB0281 - Baseline coagulation factor levels determine desmopressin response in bleeding disorders: a systematic review and meta-analysis

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0278 - Current practice regarding Bleeding Disorder of Unknown Cause (BDUC) in the Netherlands: a national survey

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0285 - Diagnosing and treating Bleeding Disorder of Unknown Cause: an illustrated review on current practice and future directions

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0003 - Time trends in vitamin K antagonist (VKA) treatment in the Netherlands in an era of transition to DOACs and lowering of VKA target intensity

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• OC 23.3 - Concurrent use of novel antidiabetic drugs and risks of adverse events among atrial fibrillation patients receiving chronic anticoagulation

  Sunday, June 23, 2024
  15:15 – 15:30 ICT

• OC 37.1 - Advanced hemostasis testing by quantitative proteomics

  Monday, June 24, 2024
  09:30 – 09:45 ICT

• PB0525 - Real-world Bleeding Rates on Emicizumab using Digital Treatment Diary data

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• PB0983 - Frequency of discontinuation of vitamin K antagonists and occurrence of bleeding and thromboembolic events in long-term users with a limited life expectancy

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT

• PB0981 - Vitamin K antagonist treatment quality in the last year of life: a multicentre observational cohort

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT